Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
or

Opko Health Inc (OPK)

Opko Health Inc (OPK)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.6600 unch (unch) 04/01/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.6700 +0.0100 (+0.60%) 19:34 ET
Quote Overview for Tue, Apr 1st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.6400
Day High
1.6900
Open 1.6700
Previous Close 1.6600 1.6600
Volume 2,572,400 2,572,400
Avg Vol 4,230,015 4,230,015
Stochastic %K 7.59% 7.59%
Weighted Alpha +23.30 +23.30
5-Day Change -0.1400 (-7.78%) -0.1400 (-7.78%)
52-Week Range 1.1500 - 2.0350 1.1500 - 2.0350
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,114,773
  • Shares Outstanding, K 671,550
  • Annual Sales, $ 713,140 K
  • Annual Income, $ -53,220 K
  • EBIT $ -69 M
  • EBITDA $ 31 M
  • 60-Month Beta 1.70
  • Price/Sales 1.60
  • Price/Cash Flow 24.71
  • Price/Book 0.85

Options Overview Details

View History
  • Implied Volatility 79.88% ( -3.48%)
  • Historical Volatility 46.76%
  • IV Percentile 69%
  • IV Rank 34.20%
  • IV High 213.50% on 07/30/24
  • IV Low 10.42% on 06/17/24
  • Put/Call Vol Ratio 0.06
  • Today's Volume 17
  • Volume Avg (30-Day) 2,733
  • Put/Call OI Ratio 0.08
  • Today's Open Interest 100,002
  • Open Int (30-Day) 307,219

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.07
  • Number of Estimates 4
  • High Estimate -0.05
  • Low Estimate -0.08
  • Prior Year -0.12
  • Growth Rate Est. (year over year) +41.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.6400 +1.22%
on 04/01/25
Period Open: 1.7400
2.0350 -18.43%
on 03/05/25
-0.0800 (-4.60%)
since 02/28/25
3-Month
1.4300 +16.08%
on 01/10/25
Period Open: 1.4700
2.0350 -18.43%
on 03/05/25
+0.1900 (+12.93%)
since 12/31/24
52-Week
1.1500 +44.35%
on 05/08/24
Period Open: 1.3100
2.0350 -18.43%
on 03/05/25
+0.3500 (+26.72%)
since 04/01/24

Most Recent Stories

More News
OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders

OPK : 1.6600 (unch)
ENTX : 1.6300 (-4.12%)
Opko Health (OPK) Q4 2024 Earnings Call Transcript

OPK earnings call for the period ending December 31, 2024.

OPK : 1.6600 (unch)
OPKO Health: Q4 Earnings Snapshot

OPKO Health: Q4 Earnings Snapshot

OPK : 1.6600 (unch)
OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results

OPK : 1.6600 (unch)
OPKO Health to Report Fourth Quarter 2024 Financial Results on February 27, 2025

OPK : 1.6600 (unch)
OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference

OPK : 1.6600 (unch)
OPKO Health’s ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck

OPK : 1.6600 (unch)
3 Stocks That Wall Street Insiders Can’t Stop Buying

Insider trades are a telling indicator of C-Suite conviction but aren't always the signal for investors they could be. Only two of these stocks are good buys.

VSTS : 9.61 (-2.93%)
GEF : 55.25 (+0.47%)
OPK : 1.6600 (unch)
CTAS : 207.87 (+1.14%)
UNF : 175.36 (+0.78%)
Insider Purchase: CEO & Chairman of $OPK (OPK) Buys 500,000 Shares

PHILLIP MD ET AL FROST, the CEO & Chairman of $OPK ($OPK), bought 500,000 shares of the company on 12-11-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased...

OPK : 1.6600 (unch)
Insider Purchase: CEO & Chairman of $OPK (OPK) Buys 199,072 Shares

PHILLIP MD ET AL FROST, the CEO & Chairman of $OPK ($OPK), bought 199,072 shares of the company on 11-29-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased...

OPK : 1.6600 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and...

See More

Key Turning Points

3rd Resistance Point 1.7367
2nd Resistance Point 1.7133
1st Resistance Point 1.6867
Last Price 1.6600
1st Support Level 1.6367
2nd Support Level 1.6133
3rd Support Level 1.5867

See More

52-Week High 2.0350
Fibonacci 61.8% 1.6969
Last Price 1.6600
Fibonacci 50% 1.5925
Fibonacci 38.2% 1.4881
52-Week Low 1.1500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies